MediWound (MDWD) Cash from Financing Activities (2013 - 2025)
MediWound (MDWD) recorded quarterly Cash from Financing Activities of -$1.1 million in Q4 2025, down 103.58% quarter-over-quarter from $30.5 million in Q3 2025, and down 112.87% on a YoY basis from $8.5 million in Q4 2024.
MediWound (MDWD) Cash from Financing Activities (2013 - 2025) Analysis & Trends
MediWound's Cash from Financing Activities history runs 13 years deep, the most recent figure standing at -$1.1 million for Q4 2025.
- In Q4 2025, Cash from Financing Activities fell 112.87% year-over-year to -$1.1 million; the TTM figure through Dec 2025 stood at $29.6 million (up 52.73% YoY), while the FY2025 annual figure was $29.6 million, up 52.73% from the prior year.
- Cash from Financing Activities was -$1.1 million for Q4 2025 at MediWound, down from $30.5 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $30.5 million in Q3 2025 to a low of -$1.1 million in Q4 2025.
- Historically, Cash from Financing Activities has averaged $5.9 million across 5 years, with a median of -$174000.0 in 2021.
- The sharpest annual moves came in 2021 and 2022: Cash from Financing Activities tumbled 808.0% in 2021, then surged 8370.06% in 2022.
- A 5-year view of Cash from Financing Activities shows it stood at -$177000.0 in 2021, then soared by 8370.06% to $14.6 million in 2022, then sank by 101.39% to -$204000.0 in 2023, then tumbled by 151.47% to -$513000.0 in 2024, then plunged by 112.87% to -$1.1 million in 2025.
- The last three Cash from Financing Activities figures came in at -$1.1 million (Q4 2025), $30.5 million (Q3 2025), and $549000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 7.00 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -600,000.00 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 53,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -538.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 85,464.43 |
| 10 | MediWound | 3.70 Mn | 3.70 Mn | 278,000.00 | -1.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.09 Mn |
| Dec 31, 2025 | -1.09 Mn |
| Sep 30, 2025 | 30.53 Mn |
| Sep 30, 2025 | 30.53 Mn |
| Jun 30, 2025 | 549,000.00 |
| Jun 30, 2025 | 549,000.00 |
| Mar 31, 2025 | -362,000.00 |
| Mar 31, 2025 | -362,000.00 |
| Dec 31, 2024 | -513,000.00 |
| Dec 31, 2024 | -513,000.00 |
| Sep 30, 2024 | 20.71 Mn |
| Sep 30, 2024 | 20.71 Mn |
| Jun 30, 2024 | -103,000.00 |
| Jun 30, 2024 | -103,000.00 |
| Mar 31, 2024 | -699,000.00 |
| Mar 31, 2024 | -699,000.00 |
| Dec 31, 2023 | -204,000.00 |
| Dec 31, 2023 | -204,000.00 |
| Sep 30, 2023 | -727,000.00 |
| Sep 30, 2023 | -727,000.00 |